Cargando…
Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
BACKGROUND: The aim of this study was to compare the clinical characteristics, causes of death and factors impacting on the prognosis of patients with idiopathic pulmonary fibrosis (IPF) and other fibrosing interstitial lung disease (FILD) with a history of acute exacerbation (AE) of IPF or FILD. ME...
Autores principales: | Salonen, Johanna, Purokivi, Minna, Bloigu, Risto, Kaarteenaho, Riitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254157/ https://www.ncbi.nlm.nih.gov/pubmed/32265195 http://dx.doi.org/10.1136/bmjresp-2020-000563 |
Ejemplares similares
-
National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care
por: Salonen, Johanna, et al.
Publicado: (2022) -
Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020) -
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial
por: Maher, Toby M, et al.
Publicado: (2018) -
Responsiveness and meaningful change thresholds of the Living with Pulmonary Fibrosis (L-PF) questionnaire Dyspnoea and Cough scores in patients with progressive fibrosing interstitial lung diseases
por: Swigris, Jeffrey J, et al.
Publicado: (2022) -
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
por: Flaherty, Kevin R, et al.
Publicado: (2017)